IL2 and neoplasm: Immunotherapy is an emerging strategy for cancer treatment, and interleukin-2 (IL-2) is the first immunotherapy component used to treat malignancies.[2] It can destroy tumors to prevent cancer and create a tumor microenvironment to assist in cancer formation.[3] We must develop more effective strategies to control the immune system so that it can actively combat tumor growth and prevent the onset of cancer.